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ASSESSMENT OF COGNITIVE FUNCTION IN TYPE 2 DIABETIC 
PATIENTS IN A RURAL TERTIARY HEALTHCARE FACILITY. 
ABSTRACT 
BACKGROUND  
Diabetes Mellitus is a complex metabolic disorder with increasing prevalence both 
in urban and rural areas and it poses a great public health disaster requires a greater 
responsibility on health care system for early detection and management of the 
Micro and Macrovascular complications studied extensively but cognitive 
dysfunction is one of the least noted and poorly recognised complication of both 
type 1 and type 2. Several factors including Insulin resistance mediates cognitive 
impairment and neurodegeneration. Chronic Hyperglycemia, increased duration of 
Diabetes, and increasing age of the patients are the three important factors 
influencing the impairment of cognition. Additional factors like gender, lifestyle 
factors, smoking, alcohol consumption, psychosocial factors, Vitamin D deficiency, 
Testosterone deficiency, and subclinical thyroid dysfunction have still to be 
elucidated. Glycemic status – particularly, which affects peripheral nerves in the 
somatosensory system and auditory system which in turn slows psychomotor 
responses and has cognitive effects all of which may affect. Reaction Time both 
Auditory and Visual are considered as ideal tool for measuring sensory motor 
association and performance of an individual and also has physiological 
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significance and is a simple and non invasive test for peripheral as well as central 
neural structures studied. 
AIM 
The purpose of the study is to assess the prevalence of Cognitive dysfunction in 
Type 2 Diabetic Patients in a Rural Tertiary Healthcare Facility and to correlate 
cognitive function through MMSE and visual and auditory reaction time with 
respect to multiple factors like age, sex, gender, education, BMI, lifestyle factors, 
smoking, alcohol and diet.  
MATERIALS AND METHODS: 
This is a Cross sectional study done in 376 Type 2 Diabetic patients aged 
30-60 years of both gender, after getting approval from the Institutional Ethics 
Committee in the OPD & IPD of our institution. After explaining the need and the 
procedures involved in the study and getting written consent, the study participants 
are subjected to the detailed general and systemic examination. Biochemical 
parameters are noted with the available record. Cognitive function was assessed 
using Mini Mental State Examination [MMSE] and Visual and Auditory Reaction 
time assessed using the apparatus “Reaction time analyser_501-004-TR  
[Psychotronics, Bangalore]. The data recorded were analysed using appropriate 
statistical tests after testing for normality, using SPSS 17.0. A probability value of 
<0.05 is considered to be statistically significant with 95% confidence limit. 
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RESULTS AND DISCUSSION 
With the mean age group of 51.478.04years and male: female ratio of 211:165, the 
prevalence of cognitive dysfunction was found to be 62.8% (mild cognitive 
impairment - 41.3% and 21.5% - severe cognitive impairment. The median scores 
of MMSE were 22 (10-30). Diabetic men found to have better MMSE scores (23.00 
 5.87 Vs 20.52  4.2; p <0.0001) and lower visual and auditory reaction time 
(521.22 ± 199.89 Vs 560.25 ± 185.59, p – 0.05 for VRT_ Red light and 417.33 ± 
160.20Vs 468.47 ± 187.67, p- 0005 for ART, respectively). BMI shows positive 
correlation with MMSE scores (r=0.143, p=0.006). Smokers showed decreased 
MMSE scores ( p=0.001) and alcoholics showed decreased MMSE scores 
(p=0.0001) and increased visual and auditory reaction time (VRT_Green – p =0.03, 
VRT_Red – 0.02 and ART -0.02). HbA1C, fasting and post-prandial blood sugar 
levels were positively correlated with reaction time. As the level of Literacy 
decreases, cognitive impairment increases. Diet, physical activity and duration of 
diabetes were not significantly associated with cognitive impairment.       
CONCLUSION 
In this cross-sectional study on cognitive functions diabetic patients we found 
higher prevalence of cognitive impairment. Gender, glycaemic control, obesity, 
literacy, smoking, alcohol have been shown to associate with cognitive impairment.   
Keywords: Cognition, BMI, Education, Glycaemic control, MMSE, Reaction 
time and Type 2 diabetes mellitus.  
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INTRODUCTION 
 
Diabetes mellitus is a complex metabolic disease which results in 
complications that are more devastating than the disease. The common and 
most studied complications of diabetes include macro vascular complications 
like cardiovascular and peripheral vascular diseases and micro vascular 
complications like nephropathy, retinopathy and neuropathy. Cognitive 
dysfunction is one of the least noted and poorly recognized complication of 
both type 1 and type 2 diabetes mellitus, though it is gaining its importance 
in the present days.
1
 Over the past several years, evidence that showed 
impairment in brain insulin and Insulin-like Growth Factor (IGF) signaling, 
mediates cognitive impairment and neuro-degeneration has developed 
particularly in relation to mild cognitive impairment and Alzheimer 
disease(AD).
2
 The working hypothesis is that peripheral insulin resistance 
promotes or exacerbates cognitive impairment and neuro-degeneration by 
causing brain insulin resistance. Mechanistically, insulin resistance with 
deregulated lipid metabolism leads to increased inflammation, cytotoxic lipid 
production, oxidative and endoplasmic reticulum (ER) stress. Insulin 
resistance is linked to obesity, T2DM, NAFLD, metabolic syndrome, 
polycystic ovarian disease, age-related macular degeneration, and AD 
epidemics
2
 
Diabetes in older adults has become a major public health problem 
Introduction 
 
Assessment of Cognitive Function in type 2 Diabetic patients in a rural tertiary healthcare facility Page 2 
 
affecting an increasing number of individuals worldwide. Both old age and 
diabetes are independently associated with an increased risk of cognitive 
dysfunction; the risk is even greater for older adults with diabetes
3
 
The most common cognitive deficits identified in patients with type 1 
diabetes are slowing of information processing speed and worsening 
psychomotor efficiency
4
. Type-2 diabetes has been associated with a 
decrease in psychomotor speed, frontal lobe/executive function
5
, complex 
motor functioning, verbal fluency
6
, verbal memory, processing speed
7
, 
working memory
5
, immediate recall, delayed recall, visual retention and 
attention
1
  
Chronic hyperglycemia, increased duration of diabetes and the 
increasing age of the patients are the three important factors influencing the 
impairment of cognitive dysfunction in diabetics
8
. However, additional 
causal factors such as gender, lifestyle (physical and mental activity), 
smoking, alcohol consumption, psychosocial factors (social activity), vitamin 
D deficiency, testosterone deficiency, and subclinical thyroid dysfunction 
have still to be elucidated. Type 2 diabetes (T2DM) appears to be a risk 
factor for Cognitive impairment (CI)
9
. Since the prevalence of type 2 
diabetes is ever increasing, understanding both the frequency and the 
possible causes of diabetes-related cognitive impairment becomes necessary 
because CI reduces quality of life, and may cause neuropsychiatric 
symptoms and disabilities to worsen, increasing health care costs. 
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In a commentary published by Sequist
10
, a question was raised if the 
dementia and cognitive dysfunction identified in elderly subjects with type 2 
diabetes is related to their co morbidities and age, or is it the result of a 
diabetes-related process that begins years earlier. These questions are to be 
considered very crucial in every diabetic patient and it has to be attended at 
an earlier stage rather than waiting till the occurrence of dementia.  
This study was initiated with the aim of detecting the prevalence of 
mild cognitive impairment in type 2 diabetic patients and the possible factors 
that are associated with the condition.  
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REVIEW OF LITERATURE 
 
Cognition  
Ulrich Neisser, Father of cognitive psychology, has defined cognition in his 
book titled ‘Cognitive psychology’ as “all processes by which the sensory input is 
transformed, reduced, elaborated, stored, recovered, and used.” It is concerned with 
these processes even when they operate in the absence of relevant stimulation, as in 
images and hallucinations. Such terms as sensation, perception, imagery, retention, 
recall, problem-solving and thinking among others refer to hypothetical stages or 
aspects of cognition.
11
  
The word ‘Cognition’ is a late Middle English term, derived from a Latin 
word “Cognosoere” which means “get to know”. 
 
Physiology of cognition  
 A key recent advance is in understanding the functions and interrelationships 
between 3 brain networks: the central executive network (CEN), the salience 
network (SN), and the default mode network (DMN)
12
 (Table 1) 
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Table. 1. Brain Networks and Related Cognitive Processes 
 
Network Regions involved Description 
Central executive 
network (CEN) 
Dorsolateral prefontal cortex  
Posterior parietal cortex 
Active for demanding 
tasks requiring attention 
Default mode 
network (DEN) 
Posterior cingulate  
Posterior parietal cortex 
Ventromedial prefontal cortex 
Active when brain is not 
engaged in specific task  
Controls areas including 
introspection, 
autobiographical memory, 
and perception of others 
Salience network 
(SN) 
Ventrolateral prefrontal cortex 
Anterior insula 
Anterior cingulate cortex 
Involved with events 
requiring non-automatic 
response and switching 
between the DMN and 
CEN 
Source: Buckner et al
13
 and Goulden et al
14
  
 
Cognitive processes
12
  
Primarily, the brain’s task is to be aware of and to respond to the 
environment which includes the external physical world, the internal state, and the 
social world. The brain’s work is to perceive the environment, survey it, and 
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monitor it for changes, which involves cognitive processes devoted to the control, 
focus, and filtering of sensory information. The brain has to interpret and appraise 
this sensory input and identify changes occurring in the environment. This process 
involves memory to compare the present environment with the past environment. 
The brain must store, retrieve, and process information using both short-term and 
long-term memory, including sensory memories. 
When changes in the environment are perceived, the brain has to evaluate 
their significance (salience) and prepare responses with the goal of minimizing 
threats and maximizing rewards. In addition, the brain must maintain an internal 
representation of other current goals and modulate actions toward their 
achievement. This cognitive activity has both a mental component and a bodily 
preparation component. The mental component involves a switch from the DMN, 
which is engaged when nothing unusual is occurring, to the engagement of the CEN 
and activation of executive functions. Bodily preparation involves connections from 
the CEN, SN, DMN, and other cortical and higher brain regions to the basal 
ganglia, hypothalamus, midbrain, and other regions that enable communication with 
and control of other organs and body systems.  
 
Neuro-cognitive domains 
The DSM-5 defines six key domains of cognitive function (Figure 1), and 
each of these has subdomains. Identifying the domains and subdomains affected in 
a particular patient can help establish the aetiology and severity of the 
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neurocognitive disorder. Objective assessments are essential, but the DSM-5 does 
not name any proprietary tests
15 
 
 
Figure 1. Six neurocognitive domains
15 
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Factors affecting cognition 
Cognitive factors refer to characteristics of the person that affect 
performance and learning which serve to modulate performance such that it may 
improve or decline. These factors involve cognitive functions like attention, 
memory, and reasoning.
16
  
Cognitive factors are internal to each person and serve to modulate behaviour and 
behavioural responses to external stimuli like stress. Performance on various daily 
living activities has been found to be affected by these factors. Executive functions, 
for example, have been shown to predict ability to live independently in older 
adults.
17
 
 
Cognition and diabetes  
Type 2 diabetes – The problem statement 
Diabetes is a potential epidemic in India with more than 62 million diabetic 
individuals currently diagnosed with the disease.
18
 According to Wild et al
19
 the 
prevalence of diabetes is predicted to double globally from 171 million in 2000 to 
366 million in 2030 with a maximum increase in India. It is predicted that by 2030 
diabetes mellitus may afflict up to 79.4 million individuals in India, while China 
(42.3 million) and the United States (30.3 million) will also see significant increases 
in those affected by the disease
19
  
Preliminary results from a large community study conducted by the Indian 
Council of Medical research (ICMR) revealed that a lower proportion of the 
Review of Literature 
 
Assessment of Cognitive Function in type 2 Diabetic patients in a rural tertiary healthcare facility Page 9 
 
population is affected in states of Northern India (Chandigarh 0.12 million, 
Jharkhand 0.96 million) as compared to Maharashtra (9.2 million) and Tamil Nadu 
(4.8 million).
20
  
The National Urban Survey conducted across the metropolitan cities of India 
reported similar trend: 11.7 % in Kolkata (Eastern India), 6.1 % in Kashmir Valley 
(Northern India), 11.6 % in New Delhi (Northern India), and 9.3 % in West India 
(Mumbai) compared with 13.5 % in Chennai (South India), 16.6 % in Hyderabad 
(south India), and 12.4 % in Bangalore (South India).
21
 
This high prevalence of diabetes in India is multifactorial including genetic, 
environmental and socio-cultural factors. There are two important differences in the 
epidemiology of diabetes in India. First, the age of onset of diabetes is a decade 
lower (20 – 40 year) in India compared to Caucasians (>50 years). Second, obesity 
is one of the major risk factor for diabetes. In India, though the rates of overweight 
and obesity is less compared to western population, the prevalence of diabetes is 
higher. This shows that Indians are more predisposed to diabetes even at lower BMI 
compared to Europeans.
22
  
Higher incidence and prevalence of early-onset of diabetes also explains the 
development of various microvascular and macrovascular complications due to 
longer duration of the disease. A recent international study reported that diabetes 
control in individuals worsened with longer duration of the disease (9.9±5.5 years). 
23
 Among the complications, neuropathy is the most common (24.6 %) followed by 
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cardiovascular complications (23.6 %), renal issues (21.1 %), retinopathy (16.6 %) 
and foot ulcers (5.5 %).
24
  
Status of cognition in diabetes   
Cognitive dysfunction is the less recognised and least addressed, yet a 
complication which is now gaining importance. The spectrum of cognitive 
impairment ranges from mild deficits that are not detected clinically to the most 
severe clinical form, dementia. Patients with diabetes are approximately 1.5 times 
more likely to acquire cognitive decline than individuals without diabetes mellitus. 
In a large cross-sectional study by Gao et al, the authors have stated that the 
prevalence of mild cognitive impairment (MCI) and dementia in patients with type 
2 diabetes mellitus was found to be 13.5 % and 2.34 % respectively.
25
 According to 
2007 prevalence data from the Centre for Disease Control and Prevention (CDC) in 
the United States, T2DM affects nearly 24 million people in the United States 
(US).
25
 T2DM disproportionately affects the elderly age group who are at the most 
risk for cognitive impairment. Almost 25% of the population who are 60 years and 
older, had T2DM in 2007. It is important to point out that both cognitive 
impairment and T2DM are disorders that are more common in the elderly.
26
  
Mukerje et al
27
 in their study have shown that the prevalence of cognitive 
impairment in diabetic population is as high as 42% 
Mild Cognitive impairment (MCI) has been used to describe a transitional 
state between normal cognitive function and Late onset Alzheimer’s disease 
(LOAD) dementia. Individuals with MCI do not have dementia but have memory 
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complaints without loss of function in their daily activities. Intervention involving 
earlier detection of MCI is the target for the clinicians to prevent transition from 
MCI to dementia.  
Classic cardiovascular risk factors like hyperlipidaemia, diabetes and 
hypertension have shown to be associated with the risk of cognitive impairment.
28
 
Apart from these classical risk factors, additional factors such as gender, lifestyle 
(physical and mental activity), smoking, alcohol consumption, psychosocial factors 
(social activity), vitamin D deficiency, testosterone deficiency, and subclinical 
thyroid have been difficult to identify.  
In patients with type 1 diabetes, specific and global deficits involving speed 
of psychomotor efficiency, information processing, mental flexibility, attention, and 
visual perception seem to be present, while in patients with type 2 diabetes an 
increase in memory deficits, a reduction in psychomotor speed, and reduced frontal 
lobe (executive) functions have been found.
29
  
Patients with diabetes also have been found to have slower walking speed, 
lack of balance, and increased falls associated with type 2 diabetes. Coexisting 
depression in these patients further complicate the scenario.
30
 Glycaemic control 
appears to play a major role in determining the degree of cognitive dysfunction 
detected in patients with type 2 diabetes. Impaired glucose tolerance without 
diabetes is also a risk factor for cognitive dysfunction. Multiple investigations of 
patients with impaired glucose tolerance have shown them to have lower mini-
mental status exam and long-term memory scores. 
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Table 2 shows the summary of cognitive domains that have been found to be 
negatively affected by type 1 and type 2 diabetes mellitus
1
  
 
Type 1 diabetes Type 2 diabetes 
Slowing of memory* Memory* 
Psychomotor efficiency*  Verbal memory 
Attention*  Visual retention 
Memory  Working memory 
Learning  Immediate recall 
Problem solving  Delayed recall 
Motor speed Psychomotor speed* 
Vocabulary Executive function* 
General intelligence Processing speed 
Visuoconstruction* Complex motor function 
Visual perception Verbal fluency 
Somatosensory examination Attention 
Motor strength Depression 
Mental flexibility*  
Executive function  
*The cognitive domains which are more affected.   
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Pathophysiology of cognitive impairment in diabetes  
 
The underlying mechanisms of cognitive dysfunction in patients with diabetes is 
postulated to be because of the combination of four factors.  
1. The role of hyperglycaemia 
2. The role of vascular disease 
3. The role of hypoglycaemia 
4. The role of insulin resistance and amyloid. 
 
The mechanisms are pictorially explained in the figure 3.  
1. The role of hyperglycaemia 
The mechanisms by which hyperglycaemia induce the changes in 
cognitive function may be the same as how it affects the other organs, viz, 
polyol pathway activation, increased formation of advanced glycation end 
products (AGEs), diacylglycerol activation of protein kinase C, and 
increased glucose shunting in the hexosamine pathway.
31
 Animal studies 
have explained that AGE and receptors for AGE are increasingly expressed 
in cognitive impairment. But human autopsy studies are very limited and 
have given inconsistent results. Hyperglycemia causes increase in reactive 
oxygen species, particularly superoxide, which lead to increased polyol 
pathway activation and formation of AGEs, activation of protein kinase C, 
and glucose shunting in the hexosamine pathway which ultimately results 
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end organ damage and neuronal damage.
31
 Altered neurotransmitter function 
has also been documented in diabetic models in addition to hyperglycaemia-
induced end organ damage. The neurotransmitter N-methyl-D-aspartate 
(NMDA) which is involved in long-term potentiation and learning may be 
affected. Other changes in neurotransmitters may be decreased acetylcholine, 
decreased serotonin turnover, decreased dopamine and increased 
norepinephrine.
1
  
 
2. Role of vascular disease  
Patients with diabetes have a two to six-fold increased risk of 
thrombotic stroke. Autopsy changes related to vascular disease has proved 
diffuse brain degeneration, pseudocalcinosis, neve fibrosis, demyelination of 
cranial nerves and spinal cord.
32,33 
In addition to the thickening of capillary 
basement membrane, which is the hallmark of microangiopathy, coexistence 
of ischemia and hyperglycemia may be particularly detrimental to the 
brain.
34
 Even mild elevation in blood glucose levels (greater than 8.6 
mmol/liter) in humans during a cerebrovascular event correlates with poorer 
clinical recovery.
35
 One potential mechanism through which hyperglycemia 
could mediate ischemic damage is lactate accumulation. Hyperglycemia 
provides more substrate for lactate formation which leads to cellular acidosis 
and worsening of injury. Another mechanism is the glutamate accumulation 
in the setting of hyperglycemia and ischemia.
1
 Glutamate, an excitatory 
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amino acid neurotransmitter, has been shown to cause neuronal damage in 
the brain.
36
 
Figure 2. Pathophysiological mechanisms linking cognition and diabetes
1
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3. Role of hypoglycaemia 
There are no general consensus regarding the contribution of hypoglycaemia 
in cognitive impairment and it is said to be controversial. In a study by Patrick et 
al
37
 they have found that the cortex, basal ganglia, and hippocampus appear to 
be most vulnerable to hypoglycaemia. Laminar necrosis and gliosis have been 
seen in these regions on autopsies performed in human patients who died of 
hypoglycaemia. In animal models, hypoglycaemia-induced neuronal damage 
seems to be selective to neurons with sparing of astrocytes and 
oligodendrocytes.
38
 There may also be a relationship to hypoglycemia during 
early nocturnal sleep, during which consolidation of memories occurs, and 
hence are prone to cognitive dysfunction. When compared to euglycemic 
clamping during sleep, hypoglycemic clamping in subjects with type 1 diabetes 
have resulted in impaired declarative memory.
39
  
 
4. The role of Insulin resistance and amyloid 
Like any other organ systems in our body, the brain requires insulin and IGF 
to maintain energy metabolism, cell survival, and homeostasis. In addition, insulin 
and IGFs support neuronal plasticity and cholinergic functions, which are needed 
for learning, memory, and myelin maintenance. Impairments in insulin and IGF 
signalling due to receptor resistance or ligand deficiency, disrupt energy balance 
and disable networks which support a broad range of brain functions
2
. Evidence 
shows that impairment in brain insulin and IGF signalling mediates cognitive 
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dysfunction and neurodegeneration that result in mild cognitive impairment and 
Alzheimer disease (AD). Though the fact that amyloid deposits and phospho-tau–
associated neuronal cytoskeletal lesions account for some AD-associated brain 
abnormalities, they are not well-documented deficits in brain metabolism in the 
very early stage of the disease. Metabolic derangements seen in AD are similar to 
those in both type 1 type and 2 diabetes mellitus.  
The deficits in signalling through progrowth, proplasticity, and prosurvival 
pathways are the consequences of insulin/IGF receptor resistance and ligand 
deficiency seen in cognitive impairment and neurodegeneration.
2
  Such insulin 
resistance states are found in many other peripheral diseases like obesity, type 2 
diabetes mellitus, non-alcoholic fatty liver disease (NAFLD) and metabolic 
syndrome (Figure 3) 
 One of the working hypothesis is to relate the brain insulin resistance with 
peripheral insulin resistance that seem to exacerbates cognitive impairment and 
neurodegeneration. Increased inflammation, cytotoxic lipid production, oxidative 
and endoplasmic reticulum (ER) stress, and worsening of insulin resistance are 
because of the consequences of insulin resistance with dysregulated lipid 
metabolism 
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Figure 3. Spectrum of insulin-resistance diseases. 
 
 
Picture reproduced after getting permission from Endocrinol Metab Clin North Am. 
2014 Mar; 43(1): 245–267. Published online 2013 Dec 12. doi:  
10.1016/j.ecl.2013.09.006 
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Assessment of cognitive dysfunction in patients with type 2 diabetes 
Cognition has been added to some standards of diabetic care, with practice 
recommendations to perform cognitive screening or ongoing cognitive assessment 
in the context of glycemic control or poor diabetes self-management.
40
 The table 3 
represents the different modalities of assessing cognitive functions in a clinical 
setup. 
TABLE 3. Modalities for assessment of cognitive dysfunction in diabetes  
Neurocognitive testing 
Evoked response potentials 
EEG 
MRI 
fMRI 
SPECT 
PET 
 
Neurocognitive testing 
Neurocognitive tests are most commonly done in clinical set-up. In testing, the 
examiner administers a battery of tests to assess different aspects of cerebral 
function. This has been the gold standard for the assessment of neurocognitive 
function. Neurocognitive tests have been very useful in assessing neurocognition in 
a variety of diseases, including diabetes, though it is cumbersome to administer and 
score. Table 4 shows the list of commonly used neurocognitive tests. 
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Table 4. Neurocognitive tests 
Cognitive test Hypothesized domain 
Mini-mental state examination Orientation, registration, short-term 
memory and language. 
Logical memory I and II 
Episodic memory 
Immediate story recall 
Delayed story recall 
Word list memory 
Word list recall 
Word list recognition 
Boston name testing 
Semantic memory 
Category verbal fluency 
Digit span forward 
Working memory Digit span backward 
Digit ordering 
Symbol digit modalities test 
Perceptual speed 
Number comparison 
Stroop colour naming 
Stroop word reading 
Judgement of line orientation 
Visuospatial ability 
Standard progressive matrices 
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Mini Mental State Examination 
The Mini-Mental State Exam (MMSE) or Folstein test is a 30-point 
questionnaire that is widely used for assessing cognitive function. The MMSE was 
first published in 1975 as an appendix to an article written by Marshal F. Folstein, 
Susan Folstein, and Paul R. McHugh.
41
 It was published in Volume 12 of the 
Journal of Psychiatric Research, published by Pergamon Press.  
It is used as a screening test for dementia in clinical practice. It is also used 
to estimate to follow the course of cognitive changes over time and to assess the 
severity and progression of cognitive impairment.  Administration of the test 
takes between 5 and 10 minutes and it includes five components of cognition, viz, 
assessment of orientation, attention, memory, language and visual-spatial skills.  
 
Advantages of MMSE 
Advantage of MMSE is that it requires no specialized equipment or training 
for administration. It has both validity and reliability for the diagnosis and 
longitudinal assessment of Alzheimer's Disease. Due to its short administration 
period and ease of use, it is useful for cognitive assessment in the OPD or bedside.  
Disadvantages of MMSE 
Disadvantages to the utilization of the MMSE is that it is affected by various 
demographic factors like age and gender. Education and occupation exert the 
greatest effect. The most frequently noted disadvantage of the MMSE is its lack of 
sensitivity to mild cognitive impairment. It also fails to adequately discriminate 
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patients with mild Alzheimer's Disease from normal patients. The content of the 
MMSE is highly verbal, lacking sufficient items to adequately measure visuospatial 
and/or constructional praxis.  
MMSE is also insensitive to impairments in executive functioning, abstract 
reasoning, and visual perception/construction. Moreover, false-positive errors might 
be more common among patients with less education and of lower socioeconomic 
status. A ceiling effect might be seen in patients with a high level of education and 
patients with MCI, because of the low level of item difficulty. Furthermore, some 
items in the MMSE were difficult to translate into another language, so they have 
been adjusted to adapt to the culture of each country
42
  
 
Validity and reliability of MMSE 
The test-retest reliability (0.80–0.95) for MMSE seems to be good and the 
sensitivity and specificity is acceptable to detect mild to moderate stages of 
dementia.
41,43,44
 Examination of its psychometric properties shows moderate-to-high 
levels of reliability, with test-retest reliability higher than the measures of internal 
consistency. Items measuring recall of three words, copy pentagon, 7s/WORLD, 
and orientation to time appear to be the most sensitive to both normal ageing and 
demanding illnesses. Criterion validity measures show high levels of sensitivity for 
moderate-to-sever levels of dementia. Construct validation studies demonstrate that 
MMSE scores correlate highly with those obtained from other types of cognitive 
screening tests.
43
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Scoring and interpretation of MMSE
45
  
The MMSE assesses the cognition of the patients with respect to orientation, 
registration, attention and calculation, recall, and language and praxis. 
 
Orientation (10 points) 
 The patient is asked for the date and then specifically for parts omitted (e.g., 
"Can you also tell me what season it is?"). One point for each correct answer.  
 The patient is asked in turn, "Can you tell me the name of this hospital 
(town, county, etc.)?" One point for each correct answer.  
 
Registration (3 points) 
 The patient is asked to say the names of three unrelated objects clearly and 
slowly, allowing approximately one second for each. After the instructor has 
said all three, the patient is asked to repeat them. The number of objects the 
patient names correctly upon the first repetition determines the score (0-3). If 
the patient does not repeat all three objects the first time, continue saying the 
names until the patient is able to repeat all three items, up to six trials. The 
number of trials taken by the patient to learn the words is recorded. If the 
patient does not eventually learn all three, recall cannot be meaningfully 
tested. 
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 After completing this task, the patient is told, "Try to remember the words, as 
I will ask for them in a little while."  
 
Attention and Calculation (5 points) 
 The patient is asked to begin with 100 and count backward by sevens. He is 
stopped after five subtractions.
93,86,79,72,65
 The total number of correct answers 
is scored. 
 If the patient cannot or will not perform the subtraction task, the patient is 
asked to spell the word "world" backwards. The score is the number of 
letters in correct order (e.g., dlrow=5, dlorw=3).  
 
Recall (3 points) 
 The patient is asked if he or she can recall the three words that the instructor 
has previously asked him or her to remember. The total numbers of correct 
answers were recorded (0-3).  
 
Language and Praxis (9 points) 
 Naming: The patient is shown a wrist watch and asked what it is. The same 
is repeated with a pencil. One point is scored for each correct naming (0-2). 
 
 Repetition: The patient to asked to repeat the sentence after the instructor 
("No ifs, ands, or buts."). Only one trial is allowed. Score 0 or 1. 
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 3-Stage Command: The patient is given a piece of blank paper and 
instructed, "Take this paper in your right hand, fold it in half, and put it on 
the floor." One point is scored for each part of the command correctly 
executed. 
 
 Reading: On a blank piece of paper the sentence, "Close your eyes," in 
letters is printed or written large enough for the patient to see clearly. The 
patient is asked to read the sentence and do what it says. One point is scored 
only if the patient actually closes his or her eyes. This is not a test of 
memory, so the instructor may prompt the patient to "do what it says" after 
the patient reads the sentence. 
 
 
 Writing: The patients are given a blank piece of paper and ask him or her to 
write a sentence for you. The sentence should not be dictated; it should be 
written spontaneously. The sentence must contain a subject and a verb and 
make sense. Correct grammar and punctuation are not necessary.  
 
 Copying: The patient is shown the picture of two intersecting pentagons and 
asked to copy the figure exactly as it is. All ten angles must be present and 
two must intersect to score one point. Tremor and rotation are ignored. 
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Interpretation of MMSE 
The table 5 shows the interpretation of MMSE scores 
Table 5. Interpretation of MMSE
45 
 
Method Score Interpretation  
Single cut-off <24 Abnormal 
Range <21 
>25 
Increased odds of dementia 
Decreased odds of dementia 
Education 21 
<23 
<24 
Abnormal for 8
th
 grade education 
Abnormal for high school education 
Abnormal for college education 
Severity 24 – 30 
18 – 23 
0 -17 
No cognitive impairment 
Mild cognitive impairment 
Severe cognitive impairment 
 
Other tests to assess cognitive function 
 
Evoked Response Potentials 
These are useful to detect sensory/ perception deficits. In a study involving type 1 
and type 2 diabetes, slowed latency of visual, somatosensory, and brainstem 
auditory-evoked potential patients is seen with type 2 diabetes whereas only slowed 
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latency of visual and somatosensory-evoked potentials was observed in patients 
with type 1 diabetes
3
 
Electroencephalogram (EEG) 
EEG can also assess spontaneous cerebral electrical activity and has been used in 
patients with type 1 and type 2 diabetes. In patients with type 2 diabetes, it has has 
been found to have slowing in the EEG frequency band analysis over the central 
cortex area and reduction of alpha activity over the parietal area
4 
 
Magnetic resonance imaging (MRI) 
White matter hyperintensities have been noticed to correlate with reduced 
performance on tests of attention, executive function, information processing speed, 
and memory in patients with type 2 diabetes. Researchers have hypothesized that 
White matter hyperintensities  could represent demyelination, increased water 
content, angionecrosis, cystic infarcts, or gliosis.
5
 Hippocampal and amygdala 
atrophy has also been  demonstrated in subjects with type 2 diabetes by MRI
6
  
Functional MRI (fMRI) 
Functional MRI (fMRI) has also been used to assess cerebral function in patients 
with diabetes. The principle of fMRI is based on increase in cerebral blood flow and 
metabolism during stimulus-induced neuronal activation. It is also accompanied by 
a relative reduction in deoxyhemoglobin content of the activated tissue which is a 
paramagnetic molecule, that can be pictured by MRI.
4
 Rosenthal et al
7
 utilised 
fMRI to the study of cerebral function during standard neurocognitive testing in 
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subjects with type 1 diabetes who were subjected to both euglycemia and 
hypoglycemia. It was found from their study that the effect of acute hypoglycemia 
on cerebral blood flow is task and region specific. For example, during 
hypoglycemia, the slower finger tapping corresponded to decreased activation of the 
right premotor cortex, supplementary motor area, and left hippocampus and with 
increased activation in the left cerebellum and right frontal pole. In addition, during 
hypoglycemia deterioration of four-choice reaction time correlated with reduced 
activation in the motor and visual systems but with increased activation of the part 
of the parietal cortex involved in planning
7
. 
SPECT and PET 
There has been growing utility of SPECT, PET, and diffusion tensor imaging in 
monitoring or detecting changes cognitive dysfunction in patients with diabetes.
4
 
Cerebral perfusion can be assessed accurately using SPECT. It has been 
demonstrated in patients with type 2 diabetes and dementia, higher incidence of 
hypoperfusion is observed in at least one area of the brain. PET with 
fluorodeoxyglucose is a technique that is based on glucose metabolism where the 
compound is taken up and trapped in the cell by phosphorylation.
4
 The studies done 
on the utilisation of PET scan on diabetes are very less and are with inconsistent 
results.  
 Reaction Time 
Simple reaction time (SRT) tests are a measure of processing speed, where 
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subjects simply respond as fast as possible to a stimulus. SRTs were first studied by 
Francis Galton in the late 19th century.
8
 Significant correlations between SRT 
latencies of processing speed and measures of fluid intelligence have been stated in 
many recent studies.
46,47
  
The effects of factors that have been found to significantly influence SRT 
like age, sex, and education has been analyzed in detail using computer-based 
paradigm.  
Auditory and visual reaction time is considered as an ideal tool for 
measuring sensory motor association.
11
 Reaction time (RT), is the time between the 
application of a stimulus which can be of any sensory modality like visual, auditory, 
pain, touch or temperature and the behavioral response. It is a good index of 
processing speed of CNS. The behavioral response is typically a button press but 
can also be an eye movement, a vocal response, or some other observable 
behavior.
12
  
Apart from being an index of processing speed, reaction time is also used to 
measure the ability in processing information and in judging the ability to 
concentrate and coordinate.
13, 14
  
Types of reaction time 
There are 3 different types of reaction time experiments, simple, recognition, 
and choice reaction time experiments. In simple reaction time experiments, there is 
only one stimulus and one response. In recognition reaction time experiments, there 
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are some stimuli (the “memory set”) that should be responded to and others (the 
“distracter set”) that should not be responded to. In choice reaction time 
experiments, there are multiple stimuli and multiple responses and subject must 
give a response that corresponds to the stimulus. It was reported that the time for 
motor preparation (e.g., tensing muscles) and motor response was the same in all 
three types of reaction time tests, implying that the differences in reaction time are 
due to processing time
15
  
 
Normal reaction time 
Average Reaction Time for human is as follows  
1. Visual RT  - 0.25 seconds 
2. Auditory RT  - 0.17 seconds 
3. Somatosensory RT - 0.15 seconds  
Auditory stimulus takes only 8-10 ms to reach brain. But visual stimuli take 
20-40ms. Therefore, auditory stimuli reach the cortex faster than the visual 
stimulus. 
Factors affecting reaction time 
Factors that can affect the average human RT include age, sex, left or right 
hand, central versus peripheral vision, practice, fatigue, fasting, breathing cycle, 
personality types, exercise, and intelligence of the subject.
16
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Reaction time apparatus 
RT apparatus is a simple circuitry which has two sides – examiner side (E) 
and subject side (S). There are 5 keys on the Examiners (E) side. Keys for Red light, 
green light, sound, click and touch. By pressing a key, the respective stimulus can 
be presented to the Subject (S). On the S side, there are two keys and a light box. 
By releasing the key connected with the stimulus, the S has to respond. In between 
the S keys and E keys, there is a metallic screen, so that S may not see which key 
will be pressed to present the stimulus. 
 
Picture of reaction time analyser 
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AIM OF THE STUDY 
 
This study is aimed to assess the cognitive functions and its correlates 
in patients with type 2 diabetes mellitus 
 
 
OBJECTIVES OF THE STUDY 
 
1. To assess cognition by Mini-mental State Examination (MMSE) in patients 
with type 2 diabetes mellitus 
2. To measure the visual and auditory reaction time in patients with type 2 
diabetes mellitus 
3. To compare and correlate the scores of MMSE and audio-visual reaction 
time with duration of diabetes, glycemic index, gender, BMI, life style 
factors, smoking, alcohol and literacy level of the study participants. 
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MATERIALS AND METHODS 
 
 Type of study  : Cross-sectional, Prevalence study. 
 Place of study  :  OPD and IPD, Department of Medicine,  
Dhanalakshmi Srinivasan Medical College 
Hospital, Perambalur. 
 Clearance from Institutional Ethics Committee has been obtained [Annexure 1]  
 Duration of study:    From January 2016 to May 2017 
o Collection of data  :  12 months  
o Analysis of data  :   2 months 
o Drafting of report  :  4 months 
 Reference population :   Patients with type 2 diabetes mellitus. 
 Source population  :  Type 2 Diabetic patients attending OPD & 
IPD of DSMCH. 
 Sample size   :  376 patients 
 Sampling method  : Simple random sampling method 
following inclusion and exclusion criteria. 
 Sample size estimation :  
Using previous literature,
3,27
 with the prevalence rate of 42%, and 
confidence level of 95% (5% confidence limit) and a design effect of 1, the 
sample size was calculated as 376.  
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Sample Selection criteria  
Inclusion criteria 
1. All patients with type 2 diabetes mellitus aged 30 to 60 years attending OPD 
and IPD of DSMCH who had given written consent to participate in the 
study. 
Exclusion criteria 
1. Patients with auditory, visual and speech problems 
2. Patients on antidepressants, antipsychotics and sedatives 
3. Patients with neuromuscular disorders 
4. Patients with history of head injury, epilepsy and Cerebro-vascular accidents 
5. Patients with localised pathology/ injury of upper limbs   
6. Patients on diabetic emergencies. 
7. Non-willing patients 
 
Method of data collection 
After explaining about the need and the procedures involved in the study and 
getting written consent [Annexure 2], the study participants will be subjected to the 
following. 
1. All the patients’ demographic profile including age, gender, education, 
occupation and detailed history regarding life style factors like smoking, 
alcohol, physical activity pattern and diet habits, duration of diabetes and 
family history of diabetes and other co-morbid illnesses are documented 
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and grading given according to the rubric given in the Tamilnadu Health 
System Project [Annexure 3]. History of claudicating pain, Peripheral 
vascular disease, Chronic kidney disease, liver disease, trauma/head 
injury, stroke/Transient ischemic attack, epilepsy, neuromuscular 
disorder, chronic intake of sedatives, antidepressants, antipsychotics, 
hypothyroidism and other audio-visual pathologies are carefully elicited.      
2. General and systemic examination including cardiovascular system, 
Respiratory system, Central nervous system and abdomen are done. 
3. Recording of BP and Pulse rate; Anthropometric measurements like 
height, weight, waist circumference and BMI were done. 
4. Cognitive function was assessed using Mini mental state examination 
(MMSE) [Annexure 4] 
5. Visual and auditory reaction time was estimated using the apparatus 
“Reaction time analyser:  501-004-TR (Psychotronics, Bangalore) 
6. Glycaemic status was assessed by estimating HbA1C levels, fasting and 
post-prandial blood sugar levels.  
a. HbA1C estimation is done by immune-turibidometry method. 
b. Fasting and post-prandial blood glucose estimation is done by 
glucose oxidase-peroxidase method. 
Data entry 
The various categorical and continuous data are entered in Excel spread 
sheet.   
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Statistical analysis  
Analysis of the data was done using SPSS software 17.0. Normality of the data is 
checked by Kolmogorov-Smirnov test. The table 6 shows the type of statistical test 
used for the analysis of various study parameters 
 
Table 6. Statistical tests used for analysis of parameters. 
 
A p value of < 0.05 at 95% confidence interval was considered to be significant. 
Parameters Statistical test used 
Age Percentage analysis  
Gender Percentage analysis 
Prevalence of cognitive dysfunction Percentage analysis 
Glycemic status and MMSE scores Spearman Correlation test 
Glycemic status and audio-visual Reaction Time Pearson Correlation test 
MMSE and Duration of diabetes and literacy  Kruskal-Wallis test 
Audio-visual Reaction Time and Duration of 
diabetes and Literacy 
One way ANOVA 
MMSE and gender, diet, physical activity, 
smoking, alcohol 
Mann-Whitney U test 
Audio-visual Reaction Time and gender, diet, 
physical activity, smoking, alcohol 
Student’s unpaired t test 
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RESULTS 
 
Cognitive assessment was done in 376 patients with type 2 diabetes mellitus 
of both gender, by MMSE and audio-visual reaction time.  
Table 7 shows the demographic and life-style characteristics of the study 
population. Age is represented as mean ± SD, whereas the other categorical 
variables Gender (Figure 4), smoking habit (figure 5), alcoholism (figure 6), 
Physical activity (Figure 7) and Diet (figure 8) and are represented as proportions. 
 
Figure 4. Gender distribution of study participants 
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Table 7. Demographic and Life-style characteristics of study population 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters  
Age (Mean ± SD) 
51.47 ± 8.04 
Gender, number (percentage)  
Males 211 (56.1) 
Females  165 (43.9) 
Smoking, number (percentage)    
Smokers  75 (19.9) 
Non-smokers  301 (80.1) 
Alcoholism, number (percentage)    
Alcoholics 143 (38) 
Non-alcoholics 233 (62) 
Physical activity, number (percentage)    
Actively involved  91 (24.2) 
Not involved  285 (75.8) 
Diet, number (percentage)    
Mixed diet 352 (93.6) 
Vegetarian 23 (6.1) 
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Figure 5. Distribution of study participants based on the habit of smoking. 
 
  
 
Figure 6.  Distribution of participants based on the habit of alcoholism 
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Figure 7.  Distribution of participants based on the physical activity 
 
    
 
Figure 8. Distribution of study participants based on diet. 
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Table 8 shows the frequency distribution of diabetic patients graded based on 
literacy level. The rubric for literacy level is based on the questionnaire developed 
by the Tamilnadu Health System Project.  
Figure 9 shows the percentage distribution of study population based on the 
level of literacy as a pie chart. 
 
Table 8. Frequency statistics of the study participants based on level of 
literacy. 
 
 
 
 
 
 
 
 
 
 
The classification of literacy level is based on the rubric developed by Tamilnadu 
health system project. 
 
 
Level of literacy Number (percentage) 
Illiterate  102 (27.1) 
Elementary  95 (25.3) 
High school 69 (18.4) 
Senior High school 67 (17.8) 
Higher secondary 16 (4.3) 
Diploma 7 (1.8) 
Degree  20 (5.3) 
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Figure 9. Percentage of study population with various literacy levels 
 
   
The distribution is represented in numbers, and percentage. 
 
Table 9 shows the anthropometric and vital signs at resting state of the study 
population. All the values are represented as mean ± SD. The figure 10 represents 
the same as a bar diagram. 
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Table 9. Anthropometric measurements and vital signs of study population  
 
Parameters Mean ± SD 
Height (in meters) 1.813 ± 0.39 
Weight (in Kilograms) 60.57 ± 11.7 
BMI 24.328 ± 4.54 
Waist circumference (in centimetres) 89.92 ± 10.92 
Systolic BP (in mm Hg) 127.15 ± 15.96 
Diastolic BP (in mm Hg) 78.90 ± 8.59 
Pulse rate (in beats per minute) 81.95 ± 8.35 
 
Figure 10. Anthropometric values of the study participants 
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Table 10 and figure 11 shows the mean values of glycaemic indicators ie. 
HbA1C, Fasting and postprandial blood sugar levels.  
 
Table 10. Glycaemic indicators of the study population 
Parameters Mean ± SD 
Hb A1C 8.35 ± 1.60 
FBS (mm Hg) 185.76 ± 63.49 
PPBS ((mm Hg) 273.63 ± 93.32 
 
FBS – Fasting blood sugar; PPBS – Postprandial blood sugar; HbA1C – 
Haemoglobin A1C 
 
Figure 11. Glycaemic indicators of the study population  
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Table 11 shows the values of various cognitive function tests done in this 
study. MMSE score, being a non-parametric variable is represented as median with 
range whereas visual and auditory reaction time is represented as mean with 
standard deviation. Figure 12 depicts the same. 
 
Table.11. Indicators of cognitive function  
 
Parameters  Mean ± SD 
MMSE score 22 (10 -30) * 
VRT_Green (milliseconds) 522.49 ± 198.88 
VRT_Red (milliseconds) 538.09 ± 194.27 
ART (milliseconds) 439.38 ± 174.31 
 
*MMSE scores are given as median (Range). 
VRT_Green, VRT_Red and ART are expressed as mean ± SD.VRT_Green – Visual 
reaction time for green light, VRT_Red - Visual reaction time for red light, ART – 
Auditory reaction time. 
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Figure 12. Indicators of cognitive functions 
 
    
 
 
Prevalence of cognition is calculated using MMSE scores. Table 12 depicts the 
prevalence of cognitive impairment based on MMSE scores.  
 
Table 12. Prevalence of Cognitive impairment 
MMSE score Number (Percentage) 
24 - 30 140 (37.2) 
< 24 236 (62.8) 
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Figure 13. Prevalence of cognitive impairment in the study population. 
 
 
 
Table 13 explains the classification of cognitive impairment based on 
severity. From the results, it is evident that 41.3 % of study population are affected 
with mild cognitive impairment and 21.5% are affected with severe impairment. 
The figure 14 also explains the same as a bar diagram.  
 
Table 13. Classification of Cognitive impairment based on MMSE scores.  
MMSE score Severity  Number (%) 
24 - 30 No impairment 140 (37.2) 
18 - 23 Mild impairment 155(41.3) 
<18 Severe impairment 81 (21.5) 
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Figure 14. Classification of cognitive impairment based on MMSE scores. 
 
 
 
 
On analysis of gender differences (Table 14 and Figure 15) in cognitive functions as 
assessed by MMSE and audio-visual reaction time, it was observed that male 
participants had significantly higher MMSE scores and lower audio-visual reaction 
time indicating that female participants have more cognitive impairment compared 
to males.  
MMSE scores were analysed by Mann Whitney U test and reaction time were 
analysed by Student’s unpaired t test. 
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Table 14. Gender differences in cognitive functions 
Parameter  Females 
(n=165) 
Males  
(n=211) 
Significance  
MMSE  20.52 ± 5.87 23.00 ± 4.20 0.0001 
VRT_Green 535.99 ± 183.95 512.43 ± 210.01 0.26 
VRT_Red 560.25 ± 185.59 521.22 ± 199.89 0.05 
ART 468.47 ± 187.67 417.33 ± 160.20 0.005 
 
MMSE scores, represented as median were analysed by Mann Whitney U test. 
Visual and auditory reaction time, represented as mean ± SD, were analysed by 
Student’s unpaired t test. 
 
Figure 15. Gender differences in cognitive functions 
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The influence of BMI on MMSE was analysed by Spearman Correlation test 
which showed strong positive correlation. The visual and auditory reaction time 
were not found to be significantly correlated with BMI.  
This result is explained in table 15 and figure 16. 
Table 15. Effect of BMI on cognition  
Parameter Correlation Coefficient Significance 
BMI Vs MMSE 0.143 0.006 
BMI Vs VRT-Green -0.062 0.23 
BMI Vs VRT_Red -0.065 0.21 
BMI Vs ART  -0.054 0.29 
 
Figure 16. Correlation between BMI and MMSE. 
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The study population has been divided into three groups based on duration of 
diabetes viz. as groups with diabetes less than 5 years, 5 to 10 years and more than 
10 years duration. Comparison of MMSE scores among the study participants 
within these three groups was done by Kruskal-Wallis test, which showed near 
significant. Table 16 and Figure 17 shows the comparison data. Comparison of 
audio-visual reaction times are done by One-way ANOVA which was not 
significant (Figure 18).  
 
Table 16. Comparison of cognitive impairment based on duration of diabetes 
 
Parameter Less than 5 
years 
(n = 233) 
5 – 10 years 
(n = 70) 
More than 5 
years 
(n=73) 
Significance  
MMSE 
score 
 
22.57 ± 5.47 22.04 ± 4.69  21.70 ± 4.51 0.05 
VRT_Green 520.19 ± 207.51 505.21 ± 153.90 550.54 ± 208.01 0.371 
VRT _ Red 530.42 ± 196.34 527.73 ± 166.23 574.69 ± 211.44  0.209 
ART 433.14 ± 173.24 432.38 ± 165.74 469.52 ± 185.93 0.276 
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MMSE scores, represented as median were analysed using Kruskal-Wallis test. 
Visual and auditory reaction time, represented as mean ± SD, were analysed by 
One-way ANOVA. 
 
 
Figure 17. Comparison of MMSE scores with duration of diabetes 
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Figure 18. Comparison of audiovisual reaction time with duration of diabetes.  
 
 
Correlation between the various glycaemic indicators and MMSE using Spearman 
Correlation test (Table 17, Figure 19, 20, and 21)) has showed that fasting blood 
sugar has significant negative correlation (r = -.102; p = 0.04) with MMSE scores 
suggesting that if fasting blood sugar increases, MMSE scores and hence cognitive 
function decreases. HbA1C and post-prandial blood sugar does not seem to 
correlate with MMSE significantly. 
Table 17. Correlation between Glycaemic indicators and MMSE. 
Parameter Correlation Coefficient Significance 
HbA1C Vs MMSE - 0.081 0.12 
FBS Vs MMSE -0.102 0.04* 
PPBS Vs MMSE -0.07 0.17 
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Figure19. Correlation between HbA1C and MMSE. 
 
Spearman Correlation test (r = -0.081; p = 0.12; Not significant) 
Figure 20. Correlation between fasting blood sugar and MMSE. 
 
Spearman Correlation test (r= -.102, p=0.04); Significant 
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Figure 21. Correlation between post-prandial blood sugar and MMSE. 
 
Spearman Correlation test (r= -.07, p=0.17); Significant 
 
Correlation was sought between Reaction time and HbA1C by Pearson Correlation 
test which showed strong positive correlation between both Visual and auditory 
reaction time. Correlation coefficient (r) and p values are given in table 18. Figure 
22, 23 and 24 represents the same in a scatter plot.  
Table 18. Correlation between HbA1C and reaction time  
Parameter Correlation 
coefficient 
Significance 
VRT_Green 0.13 0.01* 
VRT_Red 0.167 0.001* 
ART 0.103 0.04* 
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Figure 22. Correlation between HbA1C and VRT for green light  
   
Pearson Correlation test (r=0.13, p=0.01); Significant. 
 
Figure 23. Correlation between HbA1C and VRT for Red light 
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Figure 24. Correlation between HbA1C and Auditory reaction time (ART) 
 
 
 
Pearson Correlation test (r=0.103, p=0.04); Significant 
 
Correlation between fasting blood sugar and audio-visual reaction time is assessed 
by Pearson Correlation test. It was observed that the audio-visual reaction time 
showed strong positive correlation with fasting blood sugar levels. The correlation 
coefficient and significance levels are depicted in the table 19 and Figures 25, 26 
and 27. 
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Table 19. Correlation between Fasting blood sugar and reaction time  
Parameter Correlation 
coefficient 
Significance 
VRT_Green 0.182 0.0001* 
VRT_Red 0.197 0.0001* 
ART 0.132 0.01* 
 
 
Figure 25. Correlation between fasting blood sugar and VRT for green light  
 
 
Pearson Correlation test (r=0.182, p=0.0001); highly significant. 
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Figure 26. Correlation between fasting blood sugar and VRT for red light  
 
Pearson Correlation test (r=0.197, p=0.0001); highly significant. 
 
Figure 27. Correlation between fasting blood sugar and ART 
 
Pearson Correlation test (r=0.132, p=0.01); significant 
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Analysis of correlation between post-prandial blood sugar and audio-visual reaction 
time, done by Pearson Correlation test showed positive correlation with visual 
reaction time but not with auditory reaction time. The details are depicted in table 
20, figures 28, 29 and 30. 
Table 20. Correlation between postprandial blood sugar and reaction time 
Parameter Correlation 
coefficient 
Significance 
VRT_Green 0.115 0.02* 
VRT_Red 0.141 0.006* 
ART 0.068 0.19 
 
Figure 28. Correlation between post-prandial blood sugar and VRT for green 
light  
 
Pearson Correlation test (r=0.115, p=0.02); Significant. 
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Figure 29. Correlation between post-prandial blood sugar and VRT for red light  
 
Pearson Correlation test (r=0.141, p=0.006); highly Significant. 
Figure 30. Correlation between post-prandial blood sugar and VRT for red 
light  
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Pearson Correlation test (r=0.068, p=0.19); not significant. 
Based on diet, the study participants are divided into two groups, viz, Mixed diet 
group (n=352) and vegetarian diet group (n=23). MMSE scores are compared using 
Mann-Whitney U test which showed lack of significance between the two groups. 
Audio-visual reaction time was compared using Students’ unpaired t test which also 
showed no significant difference. Tables 21 and figure 31 represent the same.  
 
Table 21. Comparison of cognitive impairment based on diet 
 
Parameter Mixed diet group 
(n=352) 
Vegetarian diet group 
(n=23) 
Significance 
MMSE 21.88 ± 5.12 22.04 ± 5.12 0.79 
VRT_Green 519.01 ± 198.35 574.81 ± 208.36 0.19 
VRT_Red 534.26 ± 195.06 581.25 ± 184.99 0.27 
ART 439.20 ± 175.07 429.64 ± 152.87 0.79 
 
MMSE values were represented as median. Comparison done by Mann-Whitney U 
test. Audio-visual reaction time, represented as mean ± SD; compared by Student’s 
unpaired T test. 
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Figure 31. Comparison of cognitive impairment based on diet 
 
 
 
 
Based on involvement in physical activity, the study participants are divided into 
two groups, viz, ‘physically active’ group (n=91) and ‘physically inactive’ group 
(n=285). MMSE scores are compared using Mann-Whitney U test which showed 
lack of significance between the two groups. Audio-visual reaction time was 
compared using Students’ unpaired t test which also showed no significant 
difference. Tables 22 and figure 32 represent the same.  
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Table 22. Comparison of cognitive impairment based on physical activity  
 
Parameter  ‘With physical 
activity’ group 
(n=91) 
‘Without physical 
activity’ group 
(n=285) 
Significance  
MMSE 21.36 ± 4.34 22.06 ± 5.39 0.298 
VRT_Green 539.72 ± 192.73 516.98 ± 200.82 0.34 
VRT_Red 556.91 ± 190.35 532.08 ± 195.45 0.28 
ART 455.94 ± 179.67 434.30 ± 172.56 0.30 
 
MMSE values were represented as median. Comparison  have been done by Mann-
Whitney U test. Audio-visual reaction time represented as mean ± SD; compared by 
Student’s unpaired T test. 
Figure 32. Comparison of cognitive impairment based on physical activity. 
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Table 23 shows the comparison of cognitive impairment based on the habit of 
smoking. The study population were divided into two groups, as smokers (n=75) 
and non-smokers (n=301). MMSE scores compared using Mann-Whitney U test 
which showed significant cognitive impairment in non-smokers group. Audiovisual 
reaction time, compared using Student’s unpaired T test showed no significant 
difference. Figure 33 represents the same as a bar diagram. 
 
Table 23. Comparison of cognitive impairment based on the habit of smoking 
 
Parameter  Smokers  
(n=75) 
Non-smokers  
(n=301) 
Significance  
MMSE 21.44 ± 5.38 23.68 ± 3.70 0.001 
VRT_Green 523.24 ± 191.46 519.46 ± 227.63 0.34 
VRT_Red 542.88 ± 190.18 518.87 ± 210.15 0.28 
ART 445.06 ± 173.51 417.36 ± 176.92 0.30 
 
MMSE values, represented as median. Comparison was done by Mann-Whitney U 
test. Audio-visual reaction time, represented as mean ± SD; compared by Student’s 
unpaired T test. 
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Figure 33. Comparison of MMSE scores based on the habit of smoking.  
 
 
 
Table 24 shows the comparison of cognitive impairment based on the habit of 
alcoholism. The study population were divided into two groups, as alcoholics 
(n=143) and non-smokers (n=233). MMSE scores compared using Mann-Whitney 
U test showed highly significant cognitive impairment in non-alcoholic group. 
Audiovisual reaction time, compared using Student’s unpaired T test also showed 
significant cognitive impairment in non-alcoholic group. Figure 34 and Figure 35 
represents the same as bar diagrams. 
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Table 24. Comparison of cognitive impairment based on the habit of 
alcoholism 
Parameter  Alcoholics  
(n=143) 
Non-alcoholics  
(n=233) 
Significance  
MMSE 21.16 ± 5.65 23.08 ± 4.00 0.0001 
VRT_Green 539.18 ± 199.46 495.28 ± 195.58 0.03 
VRT_Red 555.29 ± 189.85 510.06 ± 198.74 0.02 
ART 455.29 ± 187.00 413.28 ± 148.44 0.02 
 
 
Figure 34. Comparison of MMSE based on the habit of alcoholism 
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Figure 35. Comparison of audio-visual reaction time based on the habit of 
alcoholism 
 
 
Table 25 shows the comparison of cognitive impairment with respect to the level of 
literacy among the study participants. The study population were divided into seven 
groups, as Illiterate, Elementary, High school, Senior high school, higher secondary, 
Diploma and Degree.  MMSE scores compared using Kruskal Wallis test, which 
showed highly significant cognitive impairment within the groups. As the literacy 
level increased, the MMSE scores also increased indicating that status of education 
influences cognitive function. Audio-visual reaction time, compared using one-way 
ANOVA also showed significant cognitive impairment in the groups with least 
education. Figure 36, 37and 38 represents the same as bar diagrams. 
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Table 25. Influence of literacy on cognitive functions 
 
Level of literacy MMSE VRT_Green VRT_Red ART 
Illiterate 17.86 ± 5.86 543.97 ± 191.6 566.53 ± 201.78 473.28 ± 202.22 
Elementary  20.57 ± 3.41 548.28 ± 218.26 561.32 ± 211.28 466.89 ± 188.28 
High School 23.23 ± 3.33 534.17 ± 215.65 548.17 ± 197.45  432.13 ± 166.82 
Senior high 
school 
25.07 ± 3.02 484.59 ± 164.11 496.89 ± 150.36 404.62 ± 132.08 
Higher 
secondary 
26.63 ± 2.5 477.70 ± 208.36 462.49 ± 118.11 359.82 ± 101.76 
Diploma  28.29 ± 1.38 401.3 ± 98.36  420.83 ± 118.5 367.89 ± 118.58 
Degree  27.35 ± 2.28 455.31 ± 171.19 487.47 ± 218.51 368.93 ± 85.28 
F value 38.779 1.885 2.225 2.882 
P value 0.0001 0.08 0.04 0.009 
  
MMSE scores are analysed by Kruskal-Wallis Test, whereas Visual and auditory reaction 
time are analysed by one-way ANOVA. 
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Figure 36. Comparison of MMSE scores based on level of literacy 
 
 
 
MMSE scores are represented as median and are analysed by Kruskal Wallis 
test. 
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Figure 37. Comparison of visual reaction time based on level of literacy 
 
Visual reaction time, represented as mean ± SD; compared by One-way ANOVA 
test. 
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Figure 38. Comparison of auditory reaction time based on level of 
literacy 
 
 
 
Auditory reaction time, represented as mean ± SD; compared by One-way ANOVA  
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DISCUSSION 
This cross-sectional study was done on 376 patients with type 2 diabetes 
mellitus of both gender to assess the cognitive impairment and the factors 
influencing cognition. Mohan et al
62
  in their study CURES – 9, has stated that 
though according to the WHO
45
, the mean age group of diabetic people is >65 years 
in developed countries, in India and other developing countries, the highest increase 
would occur in the age group of 45 – 64 years which includes people in the peak of 
their lives. Another study by Kumpatla et al
63
 have reported the onset of diabetes at 
a much younger age in the Indian population compared to previous years (45 ± 
10.6[2009] vs. 49.9[1999] ± 9.8 years, P < 0.0001). This study is in concurrence 
with the same with the mean age of the study population is 51.47 ± 8.04 years. 
 
Prevalence of cognitive dysfunction in diabetes. 
The primary objective of this study is to estimate the prevalence of cognitive 
impairment in patients with type 2 diabetes mellitus based on MMSE values. 
MMSE scores < 24 is set as the cut-off point, below which indicate cognitive 
impairment.
45
  Accordingly, the prevalence in this study was calculated as 62.8% 
which was very high compared to the previous studies. When classifying cognitive 
impairment based on severity, it was observed that 41.3% had mild cognitive 
impairment (MMSE scores of 18 – 23) and 21.5% had severe impairment (MMSE 
scores of <18).  Mukerje et al
27
 in their study, have shown that the prevalence of 
cognitive impairment in diabetic population is as high as 42%. Gao et al
25
 in their 
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large cross-sectional study have shown that the prevalence of mild cognitive 
impairment (MCI) and dementia in patients with type 2 diabetes mellitus was found 
to be 13.5 % and 2.34 % respectively Subha K
62
 in their study have found that the 
prevalence of cognitive impairment based on MMSE was 63.33% which is in line 
with the current study. 
Assessment of cognition using MMSE and RT 
MMSE 
In a large population-based study by A. Marseglia et al
65
, the median MMSE scores 
were observed to be 28  2.  In another study by Goh et al64, they have recorded a 
mean MMSE score of 27.7 1.5. Subha et al62 in their study have documented that 
the mean MMSE scores in diabetic people were 24.48  3.97.(3) Alenkar et al65 in a 
study including 346 diabetic patients have observed that the median score of MMSE 
was 26 with the range of 16 to 30. The median scores of MMSE in this study was 
found to be very less 22 with the range of 10 – 30. This suggests that there is an 
overall decline in cognitive function in the category of mild cognitive dysfunction 
 
Visual and auditory reaction time 
The mean visual reaction time found in our study participants was 522.49  
198.88 and 538.09  194.27 milliseconds for green and red light, respectively. 
Mean auditory reaction time was found to be 439.38  174.31 milliseconds. 
Average Reaction Time for human is 250 milliseconds to visual stimuli and 170 
milliseconds to an auditory stimulus.
66
  Both the auditory and visual reaction time is 
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increased in this study population suggesting the possibility of cognitive 
dysfunction.  
Our study shows that the ART is faster than the VRT. Similar results have 
been observed in the previous studies. Pain and Hibbs et al
67
 shows that simple 
ART has the fastest RT for any given stimulus. Research by Kemp et al 
68
 show that 
an auditory stimulus takes only 8–10 ms to reach the brain, but a visual stimulus 
takes 20-40 ms. Hence the auditory stimulus reaches the cortex faster than the 
visual stimulus, the ART is faster than the VRT. Shelton and Kumar et al
69
 also 
concluded that simple RT is faster for auditory stimuli compared with visual stimuli 
and auditory stimuli has the fastest conduction time to the motor cortex along with 
fast processing time in the auditory cortex. Our study further supports the evidence 
that ART is faster than the VRT.  
                                                         
Gender differences in cognition 
The male: female distribution in our study was 211(56.1%) and 165 (43.9%). 
In a study by Alenkar et al
65
, it was stated that men presented higher MMSE score 
than women (26.3  3.2 Vs 24.8  2.7; p <0.01). Similar results have been furnished by 
Gregg et al that They have also confirmed that the association was independent of 
age, HbA1C, hypertension, dyslipidemia and duration of diabetes.  Cynthia A. 
Munro et al
70
, in their study has concluded that men and women were 
indistinguishable on tests of auditory divided attention, category fluency, and 
executive functioning but women performed better than men on tests of 
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psychomotor speed and verbal learning and memory, whereas men outperformed 
women on tests of visuoconstruction and visual perception. Thilers et al
71
 , have  
explained that the male hormone testosterone has been related to performance on 
visuospatial tasks, and appears to have an increasing influence on these tasks with 
advancing age in men but not women (10). On the other hand, Ryan Joanne et al
72
, 
have stated that the lifetime exposure to oestrogen may be associated with better 
performance in some cognitive domains but worse performance in other cognitive 
domains. Similarly Dhangauri shenvi et al
54
 in their research have proved that both 
auditory and visual reaction time were longer in men compared to women (12) 
In this study, it was observed that the men have higher MMSE scores, visual 
reaction time for red light and auditory reaction time than women, all of which are 
in line with the previous studies. This may also be due to the fact that men had 
longer years of education than women.   
 
Cognition and duration of diabetes 
The mean duration of diabetes since diagnosis in the study population is 6.17  6 
years. It was found that the as the duration of diabetes increased, the MMSE scores 
decreased and the visual and auditory reaction time were increased though it was 
not statistically significant. This shows that the duration of diabetes has no bearing 
over cognition. Similar results have been observed in Bruce et al
73
 who stated that 
for each 5 years increase in the duration, risk of cognitive impairment increased by 
the odds ratio of 1.69. Marseglia et al
63
 has also observed a similar finding that the 
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duration of diabetes has no association with cognitive function. In another study by 
Gregg et al
74
, they have stated that the odds of cognitive impairment increases with 
increase in the duration of diabetes as assessed by Digit Symbol and Trails B tests. 
Rebecca et al
75
 have proved that duration of T2D was associated with executive 
functions. The longer the duration, the greater will be the impact of hyperglycemia 
and other risk factors of cognitive dysfunction. Rebecca et al
75
 explains that the 
relationships of duration of T2D with cognitive domains other than episodic 
memory, i.e. executive functions, semantic categorization, and attention, working 
memory, became stronger with poorer glycemic control which in turn  suggest that 
duration of disease alone may not affect cognition if HbA1c is well controlled over 
many years.   
Cognition and Body Mass Index  
The mean BMI of the study population was 24.328 ± 4.54. In this study, it 
was observed that as the BMI increased, the cognitive impairment was found to be 
less as suggested by better MMSE scores. This shows that overweight and obesity 
has a protective role against cognitive impairment.  
Similar results have been observed by few studies where they have proved that  
individuals with high BMI (BMI>25 kg/m2) have been observed to have a lower 
risk of cognitive impairment.
76,77
 A large study on Korean population has stated that 
increased BMI at later years of age has shown less association with cognitive 
impairment.
78
 On the contrary studies have also shown that impaired glucose 
tolerance and central obesity, have found reduced performance on mental status 
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exams as well as reduced performance on processing speed, attention, executive 
functioning, and learning and recall.
79
   The effect of BMI on cognition is still 
controversial and is not clear whether it is protective or detrimental. 
 
Cognition and glycemic indicators 
 The glycemic indicators (mean ± SD) that were used in this study were 
HbA1C (8.35 ± 1.6), fasting blood sugar (185.76 ± 63.49) and post-prandial blood 
sugar (273.63 ± 93.32). It was observed that fasting blood sugar showed negative 
correlation with MMSE scores indicating that as fasting blood sugar increases 
cognitive impairment increases. Similarly, HbA1C, fasting and post-prandial blood 
sugar showed strong positive correlation with reaction time. This clearly shows that 
poorer the glycemic status, worse is the cognitive impairment.     
 One study in postmenopausal women found that the risk of MCI and 
dementia increased with each 1% elevation in glycosylated hemoglobin, which is a 
stable measure of glucose.
80
 Type 2 diabetes is a state of hyperinsulinemia and 
insulin resistance. It is also postulated that higher levels of insulin resistance are 
correlated to poorer attention.
26
  Post-prandial glucose levels are reflected by 
HbA1C rather than fasting glucose values.  
HbA1c has been shown to reflect postprandial glucose elevations more than 
fasting glucose values in T2DM.
81
 and it has been proved that oscillations in 
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glucose are associated with accelerated oxidative stress and deleterious effects in 
both non-diabetics and individuals with T2DM. The effects of post-prandial 
hyperglycaemia could contribute to the frontal lobe-based cognitive dysfunction.  
Although individuals with uncontrolled diabetes had lower cognitive performance 
than those with controlled diabetes, there were no statistically significant 
differences.
63
 Prospective studies have suggested that with improvement of 
glycemic control, cognitive impairment also improved.
82
  ACCORD-MIND study 
that reported 40 months of intensive diabetes treatment (compared to standard care) 
had no benefit on several measures of cognition
83
  The current study has once again 
proved the fact that glycaemic status is a strong predictor of cognitive impairment. 
 
Cognition and diet 
Role of diet is documented in both age-related cognitive decline and 
neurodegenerative cognitive impairment. Dietary fat and high energy compounds 
seems to be risk factors for cognitive decline whereas fish consumption and cereals 
are found to reduce cognitive impairment. Vitamin deficiencies especially with 
B12, folic acid and B6, and folates also seem to have greater impact on cognitive 
impairment. 
84,85
 
In this study, the subgroup analysis based on diet showed no significant 
difference in the tests used for assessing cognition. A clearer analysis of the diet 
pattern or a programmed diet based study on cognitive functions is needed for 
getting concrete evidence.  
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Cognition and physical activity 
Physical activity could indirectly affect cognitive functions by influencing 
mediators that provide physical and mental resources for cognition: for example, (a) 
by enhancing physical energy levels by increasing sleep quality and enabling the 
intake of adequate amounts of food to maintain energy, (b) preventing or 
postponing disease states such as diabetes and (c) providing mechanisms that 
control anxiety and depression.
86
 Active physical life keeps the blood sugar values 
in check and prevents excursions in hyperglycemia The protective effect exercise 
over cognition is proved by previous researches.
 73,87
  
In this study, the beneficial effect of exercise and physical activity is not 
significantly noticed. The reason may be that the duration and type of exercise 
could not be quantified and correlated with the cognitive functions. 
 
Cognition and smoking 
In many cross-sectional studies poorer performance in smokers was reported for 
auditory-verbal learning and/or memory
88,89
, working memory
90
 , executive 
functions
89
 , general intellectual abilities
91
, visual search speed
92,93
, processing 
speed and cognitive flexibility 
89,93
  and global cognitive function
93
 (e.g., brief 
mental status examinations such as the MMSE). The level and chronicity of 
smoking, as reflected in the number of cigarettes smoked per day, duration of 
smoking over lifetime, and/or dose-duration (i.e., pack-years) were inversely related 
to various domains of neurocognition in adults across a wide age range.
94,95
   A 
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detailed review of may cross-sectional studies by Timothy et al
96
 has concluded that 
chronic cigarette smoking appears to be associated with demonstrable abnormalities 
in brain neurobiology and neurocognition.  
This study showed that participants who are smokers have poorer MMSE scores 
suggesting that smoking affects cognition in a detrimental way. 
 
Cognition and alcohol 
 Alcohol consumption is said to have a J shaped relationship with cognitive 
function meaning that light-to-moderate consumption has shown to increase 
cognition whereas heavy consumption seems to be detrimental to cognition.
97
 
Similar to smoking, alcohol seem to affect cognitive function in a detrimental way. 
Apart from its effects on neurocognition, chronic alcoholism also leads to 
deficiencies of vitamins like thiamine, niacin and Vitamin B12, all of which are 
prone to impair cognition
98
  
 In the current study, the cognitive impairment is found to be greater in 
alcoholics when compared to non-alcoholics. The quantification is not perfectly 
done in this study hence could not comment further.  
 
Cognition and literacy level. 
Level of education is a strong influencing factor in the assessment of 
cognitive functions. Folstein, McHugh, and Fanjiang have classified the scoring 
pattern of MMSE based on level of education.
45
  Elizabeth Guerrero et al
99
 have 
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documented that higher the level of education and younger the age, better is the 
performance in the cognitive tests. Dahlke et al
100
 has stated that MMSE can be used 
as a proxy to assess literacy because it has a face value of health literacy measure. 
In this study, the influence of literacy on cognitive dysfunction was analyzed using 
MMSE as well as visual and auditory reaction time. It was found that as the level of 
literacy increases, the cognitive function scores also increase. This clearly proves 
the significance of education on cognition.     
 
  
 
 
 
 
 
Summary 
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SUMMARY OF THE STUDY 
 The prevalence of cognitive impairment found in this study is 62.8 %, of 
which 41.3 % were having mild cognitive impairment and 21.5% were 
having severe cognitive impairment. 
 The median scores of MMSE in this study was found to be very less 22 with 
the range of 10 – 30 
 The mean visual reaction time found in our study participants was 522.49  
198.88 and 538.09  194.27 milliseconds for green and red light, 
respectively. Mean auditory reaction time was found to be 439.38  174.31 
milliseconds. 
 Diabetic men were found to be having better cognition compared to women 
(MMSE score were higher; visual and auditory reaction time were lower) 
 Fasting blood sugar showed negative correlation with MMSE scores. 
Similarly, HBA1C, fasting and post-prandial blood sugar levels showed 
strong positive correlation with visual and auditory reaction time 
emphasizing that poor glycemic control is associated with cognitive 
impairment. 
 Duration of diabetes was not significantly associated with cognitive 
impairment. 
 As BMI increased, the cognitive impairment was found to be less with better 
MMSE scores proving that obesity has a protective role over cognition 
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 Diet and physical activity were not associated significantly with cognitive 
impairment. 
 Cognitive impairment was significantly greater in smokers (as evidenced by 
decreased MMSE scores) and alcoholics (as evidenced by decreased MMSE 
scores and increased reaction time) 
 Level of Literacy is a stronger influencer of cognitive function which is 
evident in both MMSE scores and reaction time. 
 
  
 
 
 
 
 
 
Limitation 
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LIMITATIONS 
 
 The Neuro-cognitive tests were not supported by objective evidence for 
structural and functional damage of the brain like MRI, SPECT, PET or 
other electro-diagnostic tests like p300. 
 Insulin resistance could have been measured to relate that to glycemic 
indicators. 
 The influence of other risk factors like thyroid dysfunction, hormonal 
factors, vitamin D, B12, B2 and folic acid has not been quantitatively 
assessed.  
 
  
 
 
 
 
 
Recommendations 
 
 
 
Recommendations 
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FUTURE RECOMMENDATIONS 
 
1. Multiple neuro-cognitive tests can be done to assess various domains of 
cognition 
2. Objective assessment of cognition can be included to have 
morphological and functional evidence. 
3. Assessment of lipid profile, hormonal status, vitamin level estimation, 
Apo E expression and insulin resistance can be done to support the 
observation.  
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ANNEXURE – 3 
 
PATIENT ID CARD (Study) 
 
Date of Screening / Study :     
Age/Sex   : 
PIN No.    :     
Husband / Father’s Name/ C/O  : 
Case / Control   :     
Address    :  
Contact No/ Email ID  : 
 
DATE OF REGISTRATION/SCREENING WITH WRITTEN INFORMED 
CONSTENT 
Name of the Patient : 
Age in year : Sex(Encircle) 1. Male 2. Female 3. Transgender         
Community : 
Address : S/O / D/O / W/O 
Door No.      :   Street    :           
Village         : 
Post office/ Taluk:               Panchayat    :    
Town/City/Dist  : 
Land Mark  :      
Contact :      MobileNo:                      
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EDUCATION : (Encircle) 
1. Illiterate 2. 1-5 Std 3. 6-8 Std 4. 9-10 Std 5. 11-12 Std
 6.Diploma  7. Degree 
 
Occupation : (Encircle): 
1. Farmer (Own Land) 2. Agriculture / Unskilled Labor 3. Skilled Worker / 
Employee – Govt 
4.  Skilled Worker / Employee – Pvt.  5. Self Employed – own Shop / Small 
Business  6. House Wife 
7. Retired   8. Professional / Big Business 9. Unemployed 
 
Monthly Income  : 
 
HABITS :(Encircle) 
SMOKING   :  (a) Currently Smoking   1. Yes               2.No      
        (b)Frequency     1. Daily              2. Occasionally     
        (c) What do you smoke 1. Cigarette     2. Beedi       3.  Others   
ALCOCHOL USE  :    (a)  In past  one month    1. Yes          2. No 
      If yes (b) frequently   1. Daily  2. Weekly once   3. Occasionally 
          ( c )Quantity   -  
SMOKELESS Tobacco  :   (a)   1. Yes            2. No 
 If yes (b) Frequency  (1) Daily  2. Weekly once   3.Occasionally    
DIET : 1. Veg               2. Mixed diet  (Non veg)    
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Physical activity : (a) Have you done any of the following activities that 
Caused Breathlessness or Increased Heart  
Rate  apart from your regular work in the past one week? 
1. BRISK WALKING 2. JOGGING 3. CYCLING 4. 
GAMES/SPORTS  5 GYM  6. OTHER 7. NIL ACTIVITY. 
(b)  If yes, specify how many days per week did you do the 
above mentioned activity? 
PHYSICAL EXAMINATION: 
1. Height………………..CMS.   2. Weight…………………KG.     3.    
Waist…………………..CMS.   4. Systolic BP………………mm Hg 
5.    Diastolic BP………………………mm Hg 6. Pulse 
Rate…………………………/min    7. Spo2…………………Percentage. 
        8.   Body Mass  Index (BMI)   
(Calculate  Tick) 
    wt in Kg 
 BMI    =  ( Ht in meters ) 
2
   
 
9. PRESENTING C/O :  
1. Polyuria   :   
2. Polyphagia      
3. Polydipsia     
4. Slow or non healing ulcer     
5. Disturbed Sleep   -  Quantity    Quality  
Classification BMI 
 
 
Normal 18.5 – 22.9  
Over Weight 23 – 24.9  
Obese 25 – 29.9  
Very Obese ≥ 30  
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10. PAST  HISTORY  : 
1. Hypertension/CAHD      :    Yes/No    /Yes/No 
2. Diabetes mellitus      :    Yes/No  
3. Claudicating Pain/Peripheral vascular  disease  :    Yes/ No 
4. Chronic Kidney Disease     : Yes/No 
5. Liver Disease      :  Yes/No 
6. Trauma / Head Injury     : Yes/No 
7. Stroke / TIA      : Yes/No 
8. Epilepsy / Neuro  Muscular Disorder    : Yes/ No 
9. Sedatives / Antidepressants/Anti psychotics   :  Yes/No 
10. Hypothyroidism      : Yes/No 
11. Any other Auditory / Visual / Speech Defects  :  Yes / No 
12. Any other local Pathology that interfere with the test modality  :Yes/ No  
11. FAMILY HISTORY : 
1. Hypertension/CAHD      :    Yes/No    / Yes/No 
2. Diabetes mellitus      : Yes/ No 
3. Chronic Kidney Disease     : Yes/ No 
4. Stroke / TIA      : Yes/No 
5. Epilepsy / Neuro  Muscular Disorder    : Yes/ No 
6. Psychiatric illness     : Yes/ No 
7. Any other Specify       :  
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12. LIFE STYLE MODIFICATION / AWARENESS: 
 
         1. Cessation of Smoking / Alcohol abstinence               
2. Use low salt   
3. Restrict Non veg (Red Meat)  
4. Uses Less fried food / Less Oil   
5. Restrict simple Sugar  
6. Increase intake of vegetables and fruits  
 
7. Avoid over eating / over weight  
 
 
8. Increase Physical activity  
9. Reduce Stress   
10. Use of MCR foot wears   
11. Regular follow up Treatment   
12. Self Medication  
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GENERAL  EXAMINATION 
Consciousness    :  Yes/No             
Orientation   : Yes/ No 
Pallor    : Yes/No 
Jaundice   : Yes/ No 
Clubbing   : Yes/No 
Pedal Edema   : Yes/ No 
SYSTEMIC EXAMINATION :  
Cardiovascular Examination  :   
Respiratory Examination   : 
Abdomen    : 
Central Nervous system    : 
Eyes    : 
ENT    : 
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ANNEXURE – 4 
 
அறிவாற்றல் மதிப்பீடு (Mini Mental State Examination) 
1. 
I. தற்ப ோது எந்த வருடம்?...............................  எண்ணிக்கை ....../1 
II. தற்ப ோது என்ன சீசன்?...............................   எண்ணிக்கை ....../1 
III. தற்ப ோது என்ன மோதம்?...............................  எண்ணிக்கை ....../1 
IV. இன்கைக்கு என்ன பததி?...............................  எண்ணிக்கை ....../1 
V. இன்கைக்கு என்ன ைிழகம?...........................................  எண்ணிக்கை ...../1. 
VI. தற்ப ோது எந்த வருடம்?...............................  எண்ணிக்கை ....../1 
 
 
2.  
I. நோம் எந்த நோட்டில் உள்ப ோம்? .........................  எண்ணிக்கை ....../1 
II. நோம் எந்த மோநிலத்தில் உள்ப ோம்? ......................... எண்ணிக்கை ...../1. 
III. நோம் எந்த ஊரில் உள்ப ோம்? .........................  எண்ணிக்கை ....../1 
IV. வடீு – எந்த முைவரியில் உள் து? ....................... எண்ணிக்கை ...../1. 
V. மருத்துவமகனயின் எந்தப் குதியில் உள்ப ோம்?.............எண்ணிக்கை 
...../1 
 
 
3. நோன் மூன்று ப ோருட்ை ின் ப யகைச் பசோல்பவன். பசோல்லி முடித்தவுடன் 
அபத ப ோன்று பசோல்ல பவண்டும். பமலும் அகத திரும் வும் ஒரு சில 
நிமிடங்ைள் ைழித்து பசோல்லச் பசோல்பவன்.  
                   பந்து / கார் / மனிதன்  
                   கண்ணாடி/ வயல் / சிவப்பு  
(ஒரு வினோடி ைோல அ வில் ஒவ்பவோன்ைோைக் கூைவும்).எண்ணிக்கை ....../3 
 
 
4. நீங்ைள் நூைிலிருந்து  ின்பனோக்ைி 7, 7 ஆைக் ைழித்துச் பசோல்லவும். 
                (93,86,79,72,65)  
               (அல்லது) 
    பசோல்லும் வோர்த்கதகய  ின்பனோக்ைிச் பசோல்லவும்  
        (ைடிைோைம், குடும் ம்)                               எண்ணிக்கை ....../5 
 
 
5.சற்று முன் உங்ை ிடம் மூன்று ப ோருட்ை ின் ப யகைச் பசோல்லி ஞோ ைம் 
கவத்துக் பைோள் ச் பசோன்பனன். அவற்கை திரும் வும் பசோல்லவும்.                                        
எண்ணிக்கை ....../3 
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6.எதிரில் உள் வரிடம் சோதோைண இரு ப ோருட்ைக  ைோட்டி ப யரிடச் 
பசோல்லவும்.  
    கை ைடிைோைம் , ப ன்சில்                      எண்ணிக்கை ....../2 
 
 
7.நீங்ைள் நோன் பசோல்லும் வோர்த்கதைக  மறு டியும் பசோல்லவும்.  
 (இல்கல, இருக்ைலோம், உடன், இல்லோவிடில், ஆனோல்) எண்ணிக்கை ....../2 
 
 
8. ஒரு ைோைிதத்கத எடுத்து எதிரில் உள் வரிடம்  
1. எடுக்ைச் பசோல்லவும் (வலது கை அல்லது இடது கை  ழக்ைம் அைிந்து 
பைோள் வும்).  
2.இைண்டோை மடிக்ைச் பசோல்லவும். 
3. தகையில் ப ோடச் பசோல்லவும்.                     எண்ணிக்கை ....../3 
 
 
9.இகதப்  டித்து அதில் இருப் து ப ோல் பசய்யவும். (ைண்ைக  மூடவும்) 
எண்ணிக்கை ....../1 
 
 
10. எகதப்  ற்ைி பவண்டுமோனோலும் ஒரு முழுகமயோன வோக்ைியத்கத ப யர், 
விகனச் பசோல் ஒரு வோக்ைியம் எழுதவும். எண்ணிக்கை ....../1 
 
 
11. இந்த  டத்கதப்  ோர்த்து வகையும். 
 பவற்றுக் ைோைிதம், அழிப் ோன் மற்றும் ப ன்சில் பைோடுத்து வகையக் 
பசோல்லவும்.  த்து முகனைள். இைண்டும் குறுக்ைோை பவட்டிக் பைோள்  
பவண்டும். பநைம் .....(ஒரு நிமிடம் )எண்ணிக்கை ....../1 
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Data sheet for Visual and Auditory reaction times 
 
    Date:    Time: 
 
Name:    Age/Sex:   Dominant hand: Right/Left 
 
 
 
S.No 
VISUAL REACTION TIME AUDITORY 
REACTION TIME 
 GREEN RED  
1.    
2.    
3.    
4.    
5.    
6.    
7.    
8.    
9.    
10.    
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Data collection procedure 
 
 
  
 
 
 
 
 
 
Master Chart 






